Anja Holm
Anja Holm is CEO, Central VetPharma Consultancy.
Meeting ReportVM3: Regulation 2019/6 on antimicrobials; requirements and availability
During the session, the speakers presented an overview of the new and revised rules and guidance, explored the major hurdles for new AMs, and discussed how we can protect existing AMs on the market through measures such as harmonisation of summaries of product characteristics (SPC) and flexible dosing labels.
